ReviewMolecules (Basel, Switzerland)2019
Review in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 223 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
223 citing papers in PubMed, 497 citations in OpenAlex.
- Bacilli the most important biocontrol agent in Brazilian agriculture: from mechanisms of action to market adoption.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026Review
- Article
- Production and Characterization of a Lipopeptide Biosurfactant fromMolecules (Basel, Switzerland) · 2026Article
- A Promising Strain for Wheat Growth Promotion and Antifungal Activity Against Fungal Phytopathogens:Microorganisms · 2026Article
- Transcriptomic Analysis Reveals the Time-Dependent Mechanism of Antifungal Activity inMicroorganisms · 2026Article
- Rhizobacteria-Induced Systemic Priming Against Fungal Pathogens Involves Hydroxycinnamic Acid Amides.Plant, cell & environment · 2026Article
- Characterization of shrimp waste-based compost and its antifungal efficacy against pathogens causing olive tree decline.World journal of microbiology & biotechnology · 2026Article
- Article
- Whole-genome and Comparative Genomic Analysis Reveal the Biocontrol and Plant Growth-Promoting Potential of Bacillus velezensis JN.Y2 Against Oat Anthracnose.Functional & integrative genomics · 2026Article
- The genomic resource of Lysinibacillus fusiformis KBD-5, a biocontrol agent with antifungal activity against Botrytis cinerea.BMC genomics · 2026Article
- DecodingPlants (Basel, Switzerland) · 2026Review
- Preventive Versus Curative Application of EndophyticPathogens (Basel, Switzerland) · 2026Article
- Draft genome sequence ofMicrobiology resource announcements · 2026Article
- Isolation and Identification of Pathogens Associated with Fruit Rot ofMicroorganisms · 2026Article
- ACR3 as a Key Regulator Antimicrobial Lipopeptide Synthesis and Efflux in Bacillus velezensis HN-1.Molecular plant pathology · 2026Article
- Intestinal microbiome in necrotic enteritis infection of broiler and comparison of treatment alternatives.Tropical animal health and production · 2026Article
- Genome-based analysis of Bacillus velezensis Bm3 isolated from a vulnerable dioxin-contaminated site in central Syria reveals mechanisms of dioxin degradation.Scientific reports · 2026Article
- Article
- Genophenotypic insights into biocontrol and growth-promoting mechanisms of Bacillus velezensis BV25 against tomato Fusarium wilt.BMC microbiology · 2026Article
- Bacillus velezensis 83 protects Arabidopsis thaliana against Botrytis cinerea by triggering JA-, and SA-dependent induced systemic resistance.Pest management science · 2026Article
163 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.